Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pfaller

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Journal of Clinical Microbiology|December 15, 2010
Use of epidemiological cutoff values to examine 9-year trends in susceptibility of Candida species to anidulafungin, caspofungin, and micafunginM Pfaller, L Boyken, R Hollis, et al.
Surgery|October 1, 1993
Postoperative pneumonia: a prospective study of risk factors and morbidityK S Ephgrave, R Kleiman-Wexler, M Pfaller, et al.
Diagnostic Microbiology and Infectious Disease|January 13, 1999
Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patientsM Pfaller, J Zhang, S Messer, et al.
Journal of Clinical Microbiology|January 7, 2011
Comparison of the broth microdilution methods of the European Committee on Antimicrobial Susceptibility Testing and the Clinical and Laboratory Standards Institute for testing itraconazole, posaconazole, and voriconazole against Aspergillus isolatesM Pfaller, L Boyken, R Hollis, et al.
Cancer Research|March 1, 1979
Effects of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide, 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea, and L-phenylalanine mustard on B16, Cloudman S91, and Harding-Passey mouse melanomasH Z Hill, G J Hill, C L Miller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1994
Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysisS Redding, J Smith, G Farinacci, et al.
Journal of Chemotherapy (Florence, Italy)|April 18, 2000
A head-on comparison of the in vitro antifungal activity of conventional and lipid-based amphotericin B: a multicenter studyC Jessup, G Reyes, A Fothergill, et al.
Journal of Clinical Microbiology|May 1, 1996
Multicenter evaluation of broth microdilution method for susceptibility testing of Cryptococcus neoformans against fluconazoleH Sanati, S A Messer, M Pfaller, et al.
Journal of Clinical Microbiology|September 1, 1994
Efficacy of microbial identification system for epidemiologic typing of coagulase-negative staphylococciD Birnbaum, L Herwaldt, D E Low, et al.
Journal of Clinical Microbiology|February 10, 2004
Multicenter comparison of the Sensititre YeastOne colorimetric antifungal panel with the NCCLS M27-A2 reference method for testing new antifungal agents against clinical isolates of Candida sppA Espinel-Ingroff, M Pfaller, S A Messer, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Journal of Clinical Microbiology|December 15, 2010
Use of epidemiological cutoff values to examine 9-year trends in susceptibility of Candida species to anidulafungin, caspofungin, and micafunginM Pfaller, L Boyken, R Hollis, et al.
Surgery|October 1, 1993
Postoperative pneumonia: a prospective study of risk factors and morbidityK S Ephgrave, R Kleiman-Wexler, M Pfaller, et al.
Diagnostic Microbiology and Infectious Disease|January 13, 1999
Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patientsM Pfaller, J Zhang, S Messer, et al.
Journal of Clinical Microbiology|January 7, 2011
Comparison of the broth microdilution methods of the European Committee on Antimicrobial Susceptibility Testing and the Clinical and Laboratory Standards Institute for testing itraconazole, posaconazole, and voriconazole against Aspergillus isolatesM Pfaller, L Boyken, R Hollis, et al.
Cancer Research|March 1, 1979
Effects of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide, 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea, and L-phenylalanine mustard on B16, Cloudman S91, and Harding-Passey mouse melanomasH Z Hill, G J Hill, C L Miller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1994
Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysisS Redding, J Smith, G Farinacci, et al.
Journal of Chemotherapy (Florence, Italy)|April 18, 2000
A head-on comparison of the in vitro antifungal activity of conventional and lipid-based amphotericin B: a multicenter studyC Jessup, G Reyes, A Fothergill, et al.
Journal of Clinical Microbiology|May 1, 1996
Multicenter evaluation of broth microdilution method for susceptibility testing of Cryptococcus neoformans against fluconazoleH Sanati, S A Messer, M Pfaller, et al.
Journal of Clinical Microbiology|September 1, 1994
Efficacy of microbial identification system for epidemiologic typing of coagulase-negative staphylococciD Birnbaum, L Herwaldt, D E Low, et al.
Journal of Clinical Microbiology|February 10, 2004
Multicenter comparison of the Sensititre YeastOne colorimetric antifungal panel with the NCCLS M27-A2 reference method for testing new antifungal agents against clinical isolates of Candida sppA Espinel-Ingroff, M Pfaller, S A Messer, et al.
Pageof 6